Your browser doesn't support javascript.
Potential Emergence of Plasmodium Resistance to Artemisinin Induced by the Use of Artemisia annua for Malaria and COVID-19 Prevention in Sub-African Region.
Ataba, Essoham; Dorkenoo, Ameyo M; Nguepou, Christèle Tchopba; Bakai, Tchaa; Tchadjobo, Tchassama; Kadzahlo, Komla Dovenè; Yakpa, Kossi; Atcha-Oubou, Tinah.
  • Ataba E; Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA) /Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Université de Lomé, Boulevard Eyadema, 01BP 1515, Lomé, Togo. fidelcab10@gmail.com.
  • Dorkenoo AM; Programme National de Lutte Contre le Paludisme, Ministère de la Santé de l'Hygiène Publique et de l'Accès Universel Aux Soins, Quartier Administratif, 01BP 518, Lomé, Togo. fidelcab10@gmail.com.
  • Nguepou CT; Faculté des Sciences de la Santé, Université de Lomé, Boulevard Eyadema, 01BP 1515, Lomé, Togo.
  • Bakai T; Ecole Supérieure des Techniques Biologiques et Alimentaires (ESTBA) /Unité de Recherche en Immunologie et Immunomodulation (UR2IM), Université de Lomé, Boulevard Eyadema, 01BP 1515, Lomé, Togo.
  • Tchadjobo T; Programme National de Lutte Contre le Paludisme, Ministère de la Santé de l'Hygiène Publique et de l'Accès Universel Aux Soins, Quartier Administratif, 01BP 518, Lomé, Togo.
  • Kadzahlo KD; Programme National de Lutte Contre le Paludisme, Ministère de la Santé de l'Hygiène Publique et de l'Accès Universel Aux Soins, Quartier Administratif, 01BP 518, Lomé, Togo.
  • Yakpa K; Programme National de Lutte Contre le Paludisme, Ministère de la Santé de l'Hygiène Publique et de l'Accès Universel Aux Soins, Quartier Administratif, 01BP 518, Lomé, Togo.
  • Atcha-Oubou T; Programme National de Lutte Contre le Paludisme, Ministère de la Santé de l'Hygiène Publique et de l'Accès Universel Aux Soins, Quartier Administratif, 01BP 518, Lomé, Togo.
Acta Parasitol ; 67(1): 55-60, 2022 Mar.
Article in English | MEDLINE | ID: covidwho-1525614
ABSTRACT
Plasmodium resistance to antimalarial drugs is an obstacle to the elimination of malaria in endemic areas. This situation is particularly dramatic for Africa, which accounts for nearly 92% of malaria cases worldwide. Drug pressure has been identified as a key factor in the emergence of antimalarial drug resistance. Indeed, this pressure is favoured by several factors, including the use of counterfeit forms of antimalarials, inadequate prescription controls, poor adherence to treatment regimens, dosing errors, and the increasing use of other forms of unapproved antimalarials. This resistance has led to the replacement of chloroquine (CQ) by artemisinin-based combination therapies (ACTs) which are likely to become ineffective in the coming years due to the uncontrolled use of Artemisia annua in the sub-Saharan African region for malaria prevention and COVID-19. The use of Artemisia annua for the prevention of malaria and COVID-19 could be an important factor in the emergence of resistance to Artemisinin-based combination therapies.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Plasmodium / Malaria, Falciparum / Artemisia annua / Artemisinins / COVID-19 / Malaria / Antimalarials Type of study: Observational study Limits: Humans Language: English Journal: Acta Parasitol Year: 2022 Document Type: Article Affiliation country: S11686-021-00489-y

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Plasmodium / Malaria, Falciparum / Artemisia annua / Artemisinins / COVID-19 / Malaria / Antimalarials Type of study: Observational study Limits: Humans Language: English Journal: Acta Parasitol Year: 2022 Document Type: Article Affiliation country: S11686-021-00489-y